July 9, 2025 10:00 AM EDTUpdated 02:17 PM
Pharma

Who pays the most in bio­phar­ma? We an­a­lyzed me­di­an pay at 177 com­pa­nies

Andrew Dunn

Senior Biopharma Correspondent

The typ­i­cal em­ploy­ee at a pub­licly trad­ed life sci­ences com­pa­ny made $224,729 last year, ac­cord­ing to an End­points News analy­sis of pay trends across the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Mer­ck drops $10B for res­pi­ra­to­ry drug­mak­er Verona Phar­ma in its first ac­qui­si­tion of 2025

Fed­er­al judge sides with FDA on its mifepri­s­tone safe­ty pro­gram

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Rev­o­lu­tion and Iambic to com­bine da­ta and AI mod­els in R&D deal for can­cer drugs

No­var­tis' brain de­liv­ery plat­form op­tion deal worth up to $175M; Neu­mora's next steps

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times